Avista Therapeutics Unveils Promising Data for Gene Therapy Targeting Retinal Disorders Avista Therapeutics has showcased its promising intravitreal capsid data for treating rare retinal diseases at ARVO 2025, raising hopes for effective therapies.

Avista Therapeutics Unveils Promising Data for Gene Therapy Targeting Retinal Disorders #United_States #Salt_Lake_City #retinal_diseases #Avista_Therapeutics #AAV_Capsid